In vitro model to study chondrogenic differentiation in tendinopathy

Area of Science:

• Biomedical Engineering
• Orthopedic Research
• Cell Biology

Background:

• The pathophysiology of midportion Achilles tendinopathy remains poorly understood, hindering effective treatment.
• Chondrogenic differentiation of tendon cells is a potential factor in Achilles tendinopathy.
• Developing an in vitro model is crucial for investigating this differentiation and exploring therapeutic targets.

Purpose of the Study:

• To investigate the presence of chondrogenic differentiation in human midportion Achilles tendinopathy.
• To establish and validate an in vitro model for studying chondrogenic differentiation in tendon explants.
• To evaluate the influence of specific modulators on chondrogenic gene expression in the developed model.

Main Methods:

• Human midportion Achilles tendinotic and healthy tendon tissues were analyzed using microscopy and RT-qPCR.
• An in vitro model was created using tendon explants cultured in a chondrogenic medium.
• The model was modulated by altering the chondrogenic stimulus and adding triamcinolone or platelet-rich plasma.

Main Results:

• Tendinotic lesions showed increased glycosaminoglycan staining and upregulated chondrogenic markers (SOX9, aggrecan, collagen 2, RUNX2).
• In vitro, tendon explants cultured in chondrogenic medium expressed higher levels of aggrecan, collagen 2, and collagen 10.
• Triamcinolone and platelet-rich plasma demonstrated an influence on the chondrogenic gene expression within the in vitro model.

Conclusions:

• Chondrogenic differentiation is an observable phenomenon in midportion Achilles tendinopathy.
• A novel in vitro model has been successfully developed to study this chondrogenic differentiation.
• This model offers a platform for investigating chondrogenic differentiation as a therapeutic target for Achilles tendinopathy.